Lastly, a neuroprotective role for Sema3C in AD was proposed as a result of the observation that upper layers of EC presented a decrease in Sema3C mRNA content with respect to lower layers in individuals with no clinical evidence of neurological disease, which may explain why upper neurons are more vulnerable to the onset of AD than those located in lower layers [132]. This evidence concerns the gene SEMA3C and nervous system disorder.